Cyclopharm Ltd. is a radiopharmaceutical company, which engages in manufacturing and selling medical and health care equipment. It operates through the Technegas and Molecular Imaging segments. The Technegas segment involves in supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment offers producing radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The company was founded in 1984 and is headquartered in Sydney, Australia.
|Market Price at 22-11-2017||$0.99|
|Price to Earnings Ratio||43.16|
|Market Capitalisation||$67.61 (million)|
|Return on Equity (ROE)||9.78%|